# Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study

- Source: PR Newswire M&A
- Published: 2026-11-03T13:15:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/lucid-diagnostics-announces-publication-of-landmark-12-000-patient-real-world-esoguard-study-302927774.html
- Canonical: https://groundlevelnews.com/story/lucid-diagnostics-announces-publication-of-landmark-12-000-patient-rea-7baf6c/

Largest peer-reviewed study of nonendoscopic esophageal precancer testing to date demonstrates the efficiency and scalability of EsoCheck® cell collection in under two minutes NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._